monitor capsule live 00:00:00

BioOrbit.

Bringing the
Hospital to Home via Space

BioOrbit-Home
From lab curiosity > To industrial capability
From complex treatments > To accessible ones
From hospital > To home
BioOrbit-home_section_1_img_1_1920x1296
BioOrbit-home_section_1_img_1_1920x1296
BioOrbit-home_section_2_img_1-3
BioOrbit-home_section_2_img_4-3
BioOrbit-home_section_2_img_5-2
BioOrbit-home_section_2_img_11-2
BioOrbit-home_section_2_img_8-2
BioOrbit-home_section_2_img_3-3
BioOrbit-home_section_2_img_7-2
BioOrbit-home_section_2_img_2-3
BioOrbit-home_section_2_img_9-2
BioOrbit-home_section_2_img_10-2
BioOrbit-home_section_2_img_6-2
BioOrbit-home_section_2_img_12
BioOrbit-home_section_2_img_1-3
BioOrbit-home_section_2_img_4-3
BioOrbit-home_section_2_img_5-2
BioOrbit-home_section_2_img_11-2
BioOrbit-home_section_2_img_8-2
BioOrbit-home_section_2_img_3-3
BioOrbit-home_section_2_img_7-2
BioOrbit-home_section_2_img_2-3
BioOrbit-home_section_2_img_9-2
BioOrbit-home_section_2_img_10-2
BioOrbit-home_section_2_img_6-2
BioOrbit-home_section_2_img_12
BioOrbit-home_section_2_img_1-3
BioOrbit-home_section_2_img_4-3
BioOrbit-home_section_2_img_5-2
BioOrbit-home_section_2_img_11-2
BioOrbit-home_section_2_img_8-2
BioOrbit-home_section_2_img_3-3
BioOrbit-home_section_2_img_7-2
BioOrbit-home_section_2_img_2-3
BioOrbit-home_section_2_img_9-2
BioOrbit-home_section_2_img_10-2
BioOrbit-home_section_2_img_6-2
BioOrbit-home_section_2_img_12
BioOrbit-home_section_2_img_1-3
BioOrbit-home_section_2_img_4-3
BioOrbit-home_section_2_img_5-2
BioOrbit-home_section_2_img_11-2
BioOrbit-home_section_2_img_8-2
BioOrbit-home_section_2_img_3-3
BioOrbit-home_section_2_img_7-2
BioOrbit-home_section_2_img_2-3
BioOrbit-home_section_2_img_9-2
BioOrbit-home_section_2_img_10-2
BioOrbit-home_section_2_img_6-2
BioOrbit-home_section_2_img_12
BioOrbit-home_section_2_img_1-3
BioOrbit-home_section_2_img_4-3
BioOrbit-home_section_2_img_5-2
BioOrbit-home_section_2_img_11-2
BioOrbit-home_section_2_img_8-2
BioOrbit-home_section_2_img_3-3
BioOrbit-home_section_2_img_7-2
BioOrbit-home_section_2_img_2-3
BioOrbit-home_section_2_img_9-2
BioOrbit-home_section_2_img_10-2
BioOrbit-home_section_2_img_6-2
BioOrbit-home_section_2_img_12

The leading scalable crystallisation platform for complex biologics

BioOrbit-home_section_3_img_1

BioOrbit is building the platform for scalable pharmaceutical manufacturing in space.

Crystals
BioOrbit-home_section_3_img_2

Crystallisation is the breakthrough. We make it scalable.

Manufacturing crystals at scale
BioOrbit-home_section_3_img_3-2

Self-injectable treatment can shift complex therapies, including oncology care, from hospital to home.

Injectable at home

Producing pharmaceutical-grade
crystals in space

Benefits of collaborating with BioOrbit on earth compaired to our enhanced space missions.
BioOrbit is pioneering scalable microgravity crystallisation for biologics.
On Earth
BioOrbit-On Earth
500μm

Producing pharmaceutical-grade
crystals in space

Benefits of collaborating with BioOrbit on earth compaired to our enhanced space missions.
BioOrbit is pioneering scalable microgravity crystallisation for biologics.
In Space
BioOrbit-In Space
500μm

Better biologic performance through crystallisation

BioOrbit-home_section_5_img_1-2
Ultra-high
concentration
At home administration
BioOrbit-At home administration
BioOrbit-home_section_5_img_2b-2
Formulation
stability
Reduced cold chain burden
BioOrbit-Reduced cold chain burden
BioOrbit-home_section_5_img_3-2
Controlled release
profiles
Less frequent treatment
BioOrbit-Less frequent treatment
BioOrbit-In Space

Principal
Consultant

“BioOrbit is operating
at a pivotal moment bridging the gap between orbital research and life-saving terrestrial medicine.
By harnessing microgravity to perfect crystalline biologic suspensions, we are not just conducting research – we are building the scalable infrastructure that will make space-enabled life sciences a cornerstone of future pharmaceutical R&D and global patient care”

Paul Reichert
Principal Consultant, Space Biologics Rx, LLC | Solving Drug Delivery & Stability via Microgravity R&D | 12 Space Shuttle & 4 ISS Missions | 04 US Patents | Advisor to BioOrbit
BioOrbit-controlled_release_profiles_new
Building the infrastructure behind tomorrow's biologics. Explore what is possible.

Recent milestones
and momentum

BIOORBIT LTD

Company status: Active Company type: Private limited Company

Nature of business (SIC):72110 – Research and experimental development on biotechnology

BioOrbit-home_section_7_img_a

BioOrbit is one of Tech Nation Future Fifty Companies! Our CEO was invited to Downing Street last week along with other Tech companies to celebrate!

BioOrbit-home_section_7_img_b

Our own CEO attended the 2025 SLUSH startup event as one of the speakers.

Watch here

BioOrbit-home_section_7_img_c

BioOrbit is one of Tech Nation Future Fifty Companies! Our CEO Katie King, PhD speaking at London Tech Week this year on the Deep Tech panel!

BioOrbit-home_section_7_img_d